Gary A. Lyons
Director · Travere Therapeutics, Inc.
IndividualSelling only19 10b5-1 trades
- 2024
- Aug 19, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gary A. Lyons files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eric M. Dube - $41.35M in TVTX purchases and sales in the last 12 months
- Peter Heerma - $18.77M in TVTX purchases and sales in the last 12 months
- William E. Rote - $14.02M in TVTX purchases and sales in the last 12 months
- Elizabeth E. Reed - $7.02M in TVTX purchases and sales in the last 12 months
- Christopher R. Cline - $4.64M in TVTX purchases and sales in the last 12 months
- Jula Inrig - $4.53M in TVTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gary A. Lyons?
Gary A. Lyons is a corporate insider, tracked as Director of Travere Therapeutics, Inc. (TVTX). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Gary A. Lyons submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Gary A. Lyons been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($3.84M) across all tracked filings.
